PDF

Aamal Signs Over QAR 1 Billion Contract with Kahramaa Awarded Last Year to Elsewedy Cables – Execution Preparations Underway

Elsewedy Cables Qatar will begin preparations to receive supply and project orders as part of the expansion of Kahramaa’s power transmission system in Qatar

PDF

Ebn Sina Medical strengthened commitment to healthcare innovation through its continued partnership with Novo Nordisk to bring Wegovy® (Semaglutide 2.4mg) to Qatar

Through its continued partnership with Novo Nordisk to bring Wegovy® (Semaglutide 2.4mg) to Qatar

PDF

"Aamal" Announces its Financial Results for the first quarter ended 31 March 2025

Reporting a solid start to 2025 and robust year-on-year growth

PDF

Aamal Company sets the date to announce its financial results for Q1 2025

Results of Aamal's Annual Extra-Ordinary and Ordinary General Assembly Meeting

The Assembly approved to distribute 6% dividend to shareholders.

PDF

Aamal’s Ebn Sina Medical Signs a Strategic Partnership with "BeiGene"

Introducing Innovative Oncology Treatments in Qatar.

PDF

Aamal Announces the Deferral of its Annual Ordinary and Extra Ordinary General Assembly Meetings

Due to lack of quorum.

"Aamal" Discloses its Financial Results for the Year Ended 31 December 2024

A robust performance in 2024 with sustained strategic progress and continued diversification.

PDF

Aamal’s Subsidiary, Aamal Trading & Distribution, Awarded for its ‘Solutions and after Sales Services’

Among All Bridgestone distributors globally.

PDF

Aamal Company Sets the Date for Announcing its Full Year Financial Results, and the Analyst Conference Call

The Analyst Conference Call will be held on Wednesday, 25th of February 2025 at 2:00 pm.